Sustained improvements in glycaemic and psychosocial outcomes for youth and caregivers using Omnipod 5 AID for 12 months
Authors' conclusion
This study demonstrates sustained improvements in glycaemic and psychosocial outcomes for youth and caregivers using the Omnipod 5 AID system for 12 months, the longest real-world evaluation of Omnipod 5 to date.
Study context
- Population
- Youth with T1D prescribed the Omnipod 5 AID system, and their caregiversyouth
- Participants
- 141 participants
- Exposure
- Baseline vs month 12 on Omnipod 5 AID
- Outcome
- HbA1c
- Follow-up
- Month 12
Methodological detailsreal-world
- Real-world
Main finding
As reported in the abstract
P < 0.001
Observational data: associations, not effects.
Further findings
| Outcome | Baseline | Month 12 | P value |
|---|---|---|---|
| TIR · month 12Increased | 58.3% (unspecified 2.8%) | 64.0 (unspecified 1.4%) | P < 0.001 |
| TBR <70 mg/dL · month 12Decreased | 3.1% (unspecified 0.2%) | 2.1% (unspecified 0.2%) | P < 0.001 |
| Caregiver INSPIRE score · month 12 | 77.4 (unspecified 1.4) | 83.6 (unspecified 1.4) | |
| Caregiver PAID score · month 12Improved | 53.3 (unspecified 1.7) | 44.2 (unspecified 1.8) | P < 0.001 |
| Youth PAID score · month 12Improved | 51.9 (unspecified 2.8) | 46.9 (unspecified 2.9) | P < 0.001 |
Caregiver INSPIRE score · month 12
- Caregivers reported improvements in all psychosocial measures, including all three hypoglycaemia fear survey (HFS) subscales
Youth HFS and INSPIRE scores · month 12
- Youth HFS scores improved in all three subscales
- No change in youth INSPIRE scores
Original publication
Sustained improvements in glycaemic and psychosocial outcomes for youth and caregivers using Omnipod 5 AID for 12 months. Diabetes Obes Metab. Published 24 June 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →